Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

495 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Characteristics and Outcomes of Patients Screened for Transcatheter Tricuspid Valve Replacement: The TriACT Registry.
Hagemeyer D, Merdad A, Sierra LV, Ruberti A, Kargoli F, Bouchat M, Boiago M, Moschovitis A, Deva DP, Stolz L, Ong G, Peterson MD, Piazza N, Taramasso M, Dumonteil N, Modine T, Latib A, Praz F, Hausleiter J, Fam NP. Hagemeyer D, et al. Among authors: hausleiter j. JACC Cardiovasc Interv. 2024 Feb 26;17(4):552-560. doi: 10.1016/j.jcin.2023.12.016. JACC Cardiovasc Interv. 2024. PMID: 38418058
Long-term risk of adverse outcomes and new malignancies in patients treated with oral sirolimus for prevention of restenosis.
Kufner S, Hausleiter J, Ndrepepa G, Schulz S, Bruskina O, Byrne RA, Fusaro M, Kastrati A, Schömig A, Mehilli J; OSIRIS Trial Investigators. Kufner S, et al. Among authors: hausleiter j. JACC Cardiovasc Interv. 2009 Nov;2(11):1142-8. doi: 10.1016/j.jcin.2009.08.015. JACC Cardiovasc Interv. 2009. PMID: 19926058 Free article. Clinical Trial.
Clinical outcomes through 12 months in patients with degenerative mitral regurgitation treated with the MitraClip® device in the ACCESS-EUrope Phase I trial.
Reichenspurner H, Schillinger W, Baldus S, Hausleiter J, Butter C, Schäefer U, Pedrazzini G, Maisano F; ACCESS-EU Phase I Investigators. Reichenspurner H, et al. Among authors: hausleiter j. Eur J Cardiothorac Surg. 2013 Oct;44(4):e280-8. doi: 10.1093/ejcts/ezt321. Epub 2013 Jul 17. Eur J Cardiothorac Surg. 2013. PMID: 23864216 Clinical Trial.
Long-term outcome of patients with severe biventricular heart failure and severe mitral regurgitation after percutaneous edge-to-edge mitral valve repair.
Orban M, Braun D, Orban M, Grebmer C, Sibbing D, Thaler R, Tittus J, Wimbauer F, Lesevic H, Sonne C, Mehilli J, Ott I, Näbauer M, Massberg S, Boekstegers P, Hausleiter J. Orban M, et al. Among authors: hausleiter j. J Interv Cardiol. 2015 Apr;28(2):164-71. doi: 10.1111/joic.12193. Epub 2015 Apr 10. J Interv Cardiol. 2015. PMID: 25858050 Free article.
Aortic regurgitation with second versus third-generation balloon-expandable prostheses in patients undergoing transcatheter aortic valve implantation.
Jochheim D, Zadrozny M, Theiss H, Baquet M, Maimer-Rodrigues F, Bauer A, Lange P, Greif M, Kupatt C, Hausleiter J, Hagl C, Massberg S, Mehilli J. Jochheim D, et al. Among authors: hausleiter j. EuroIntervention. 2015 Jun;11(2):214-20. doi: 10.4244/EIJV11I2A40. EuroIntervention. 2015. PMID: 26093840 Free article.
Collapse of a Bioresorbable Novolimus-Eluting Coronary Scaffold.
Braun D, Baquet M, Massberg S, Mehilli J, Hausleiter J. Braun D, et al. Among authors: hausleiter j. JACC Cardiovasc Interv. 2016 Jan 11;9(1):e13-e14. doi: 10.1016/j.jcin.2015.10.019. Epub 2015 Dec 9. JACC Cardiovasc Interv. 2016. PMID: 26685077 Free article. No abstract available.
495 results